Example: stock market
GUIDE TO GOOD MANUFACTURING PRACTICE …
Introduction PE 009-8 (Intro) - 1 - 15 January 2009 INTRODUCTION General In order to further facilitate the removal of barriers to trade in medicinal
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
2008 11 25 gmp-an1 - ECA Academy
academy.gmp-compliance.org2 ANNEX 1 MANUFACTURE OF STERILE MEDICINAL PRODUCTS Principle The manufacture of sterile products is subject to special requirements in order to minimize
GUIDE TO GOOD MANUFACTURING PRACTICE …
www.medsafe.govt.nzTable of contents PE 009-8 (Annexes) -i-15 January 2009 ANNEXES Annex 1 Manufacture of sterile medicinal products.....1
対訳資料：PIC/S(EU) GMP Annex 1 Draft
www.ph-s.comAdditional areas (other than sterile medicinal products) where thegeneral principles of the annex can be applied. この付属書の一般原則を適用が可能な（無菌医薬品以外の）付 …
Cleanroom For Sterile Manufacturing Facilities - …
www.gmpua.comWHO TRS No. 823 Annex 1, 1992 (1) General 17.1 The production of sterile preparations should be carried out in clean areas, entry to …
WHO good manufacturing practices for biological …
www.who.int93 Annex 2 WHO good manufacturing practices for biological products Replacement of Annex 1 of WHO Technical Report Series, No. 822 1. Introduction 96 2.
Annex 5 Supplementary guidelines on good …
www.who.int216 1. Introduction Heating, ventilation and air-conditioning (HVAC) play an important role in ensuring the manufacture of qual ity pharmaceut ical products .
20030329-01A Pharma and Life Sciences - …
www.gmpua.comwww.golighthouse.com BS 5295 Part 1 : 1989 Appendix 3 - Designation of Environmental Cleanliness Between classified area and unclassified area Between
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comPE 0092 dated - 1 July 2004 published by the Pharmaceutical Inspection Cooperation Scheme (PIC/S). The modifications to that Guide and its adoption as the South African Guide to Good Manufacturing Practice is done so …
Related search queries
2008 11 25 gmp-an1, Annex 1 Manufacture of sterile medicinal products, Manufacture of sterile products, GOOD MANUFACTURING PRACTICE, Annex 1, Sterile medicinal products, Annex, Cleanroom For Sterile Manufacturing Facilities, Of sterile, Good manufacturing practices for biological, Good manufacturing practices for biological products, Supplementary guidelines on good, Heating, ventilation and air-conditioning, Manufacture, Products, 20030329-01A Pharma and Life Sciences, MEDICINES CONTROL COUNCIL